Intermediate for Carfilzomib. Carfilzomib (trade name: Kyprolis) is an anti-cancer drug acting as a selective proteasome inhibitor. Carfilzomib has been approved by the U.S Food and Drug Administration on July 20, 2012.

Specifications

Product Name:                  (S)-tert-Butyl 1-(methoxy(methyl)amino)-4-methyl-1-oxopentan-2-ylcarbamate

Synonyms:                         N/A

CAS Number:                     87694-50-6

Molecular Weight:            274.3594

Molecular Formula:          C13H26N2O4

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               CON(C(=O)[C@@H](NC(=O)OC(C)(C)C)CC(C)C)C